138 related articles for article (PubMed ID: 2786763)
1. Expression of Thomsen-Friedenreich (TF) antigens on lymphocytes. II. Loss of cryptic TF antigens during mitogenic activation of human T and B lymphocytes.
Wolf MF; Schmitt HR; Schumacher K
Cell Immunol; 1989 Jul; 121(2):366-71. PubMed ID: 2786763
[TBL] [Abstract][Full Text] [Related]
2. Expression of Thomsen-Friedenreich (TF) antigens on lymphocytes. I. Distribution of cryptic and exposed TF antigens on murine lymphocytes from different lymphoid organs: detection with an anti-TF monoclonal antibody and peanut agglutinin.
Wolf MF; Schmitt HR; Schumacher K
Cell Immunol; 1989 Jul; 121(2):360-5. PubMed ID: 2736629
[TBL] [Abstract][Full Text] [Related]
3. Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines.
Wolf MF; Koerner U; Schumacher K
Cancer Res; 1986 Apr; 46(4 Pt 1):1779-82. PubMed ID: 2418954
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients.
Wolf MF; Ludwig A; Fritz P; Schumacher K
Tumour Biol; 1988; 9(4):190-4. PubMed ID: 3420374
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human tumor associated Thomsen-Friedenreich antigen.
Samuel J; Noujaim AA; MacLean GD; Suresh MR; Longenecker BM
Cancer Res; 1990 Aug; 50(15):4801-8. PubMed ID: 2196117
[TBL] [Abstract][Full Text] [Related]
6. Thomsen-Friedenreich antigen in bladder cancer tissues detected by monoclonal antibody.
Yokoyama M; Ohoka H; Oda H; Oda T; Utsumi S; Takeuchi M
Hinyokika Kiyo; 1988 Feb; 34(2):255-8. PubMed ID: 3376817
[TBL] [Abstract][Full Text] [Related]
7. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen.
Stein R; Chen S; Grossman W; Goldenberg DM
Cancer Res; 1989 Jan; 49(1):32-7. PubMed ID: 2461799
[TBL] [Abstract][Full Text] [Related]
8. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
9. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry.
Yuan M; Itzkowitz SH; Boland CR; Kim YD; Tomita JT; Palekar A; Bennington JL; Trump BF; Kim YS
Cancer Res; 1986 Sep; 46(9):4841-7. PubMed ID: 3731131
[TBL] [Abstract][Full Text] [Related]
10. Human peripheral blood T helper cell-induced B cell activation results in B cell surface expression of the CD23 (BLAST-2) antigen.
Crow MK; Kushner B; Jover JA; Friedman SM; Mechanic SE; Stohl W
Cell Immunol; 1989 Jun; 121(1):99-112. PubMed ID: 2524281
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
Kansas GS; Wood GS; Fishwild DM; Engleman EG
J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
[TBL] [Abstract][Full Text] [Related]
12. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.
Thurnher M; Clausen H; Fierz W; Lanzavecchia A; Berger EG
Eur J Immunol; 1992 Jul; 22(7):1835-42. PubMed ID: 1378020
[TBL] [Abstract][Full Text] [Related]
13. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
[TBL] [Abstract][Full Text] [Related]
14. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44.
Singh R; Campbell BJ; Yu LG; Fernig DG; Milton JD; Goodlad RA; FitzGerald AJ; Rhodes JM
Glycobiology; 2001 Jul; 11(7):587-92. PubMed ID: 11447138
[TBL] [Abstract][Full Text] [Related]
15. Identification of normal and transformed lymphocyte subsets of nonhuman primates with monoclonal antibodies to human lymphocytes.
Neubauer RH; Briggs CJ; Noer KB; Rabin H
J Immunol; 1983 Mar; 130(3):1323-9. PubMed ID: 6296233
[TBL] [Abstract][Full Text] [Related]
16. Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence.
Ohoka H; Shinomiya H; Yokoyama M; Ochi K; Takeuchi M; Utsumi S
Urol Res; 1985; 13(2):47-50. PubMed ID: 4012935
[TBL] [Abstract][Full Text] [Related]
17. The Thomsen-Friedenreich antigen on human urothelial cell lines detectable by peanut lectin and monoclonal antibody raised against human glycophorin A.
Radzikowski CZ; Steuden I; Wiedlocha A; Kieler J; Tromholt V
Anticancer Res; 1989; 9(1):103-7. PubMed ID: 2650614
[TBL] [Abstract][Full Text] [Related]
18. Rabbit leukocyte surface antigens defined by monoclonal antibodies.
De Smet W; Vaeck M; Smet E; Brys L; Hamers R
Eur J Immunol; 1983 Nov; 13(11):919-28. PubMed ID: 6605862
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of monoclonal antibodies reactive with porcine PBL.
Pescovitz MD; Lunney JK; Sachs DH
J Immunol; 1984 Jul; 133(1):368-75. PubMed ID: 6609988
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1.
Baldus SE; Hanisch FG; Monaca E; Karsten UR; Zirbes TK; Thiele J; Dienes HP
Histol Histopathol; 1999 Oct; 14(4):1153-8. PubMed ID: 10506931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
